SFM
IMGN

Sphera Funds Management’s Immunogen Inc IMGN Stock Holding History

Sphera Funds Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-500,000
Closed -$3.21M – 151
2017
Q4 		$3.21M Buy
+500,000
New +$3.08M 0.38% 65
2014
Q2 		– Sell
-34,500
Closed -$515K – 136
2014
Q1 		$515K Buy
+34,500
New +$544K 0.12% 103

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sphera Funds Management's IMGN Position: Q1 2018 in Review

Sphera Funds Management sold out of Immunogen Inc (IMGN) in Q1 2018, closing a stake of 500,000 shares — an estimated $3.21M sold.

Sphera Funds Management first reported a position in IMGN in Q1 2014 and held it in 2 quarters. The position peaked at $3.21M in Q4 2017. 204 funds tracked by Wall St. Rank hold IMGN as of Q1 2018.

  • Sphera Funds Management reported no remaining Immunogen Inc position as of Q1 2018 after selling out during the quarter.
  • Sphera Funds Management sold 500,000 Immunogen Inc shares in Q1 2018, an estimated $3.21M.
  • Sphera Funds Management first reported a position in Immunogen Inc in Q1 2014 and held it in 2 quarters.
  • Sphera Funds Management's Immunogen Inc position peaked at $3.21M in Q4 2017.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2018.

Based on Sphera Funds Management's 13F filing for Q1 2018, filed 10 May 2018.